SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Weisman MH, Paulus HD, Russak SM, Lubeck DP, Chiou CF, Sengupta N, et al. Development of a new instrument for rheumatoid arthritis (RA): the Cedars-Sinai Health-Related Quality of Life Instrument (CSHQ-RA). Arthritis Rheum (Arthritis Care Res) 2003; 49: 7884.
  • 2
    Scientific Advisory Committee. Instrument review criteria. Medical Outcomes Trust Bulletin I-IV; 1995.
  • 3
    Huskisson EC. Measurement of pain. J Rheumatol 1982; 9: 7689.
  • 4
    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 47383.
  • 5
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 6
    Kosinski M, Keller SD, Hatoum HT, Kong SX, Ware JE Jr. The SF-36 health survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability. Med Care 1999; 37 Suppl: MS1022.
  • 7
    Ruta DA, Hurst NP, Kind P, Hunter M, Stubbings A. Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the Short Form 36-item health survey (SF-36). Br J Rheumatol 1998; 37: 42536.
  • 8
    Tuttleman M, Pillemer SR, Tilley BC, Fowler SE, Buckley LM, Alarcon GS, et al, Minocycline in Rheumatoid Arthritis Trial Group. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. J Rheumatol 1997; 24: 19105.
  • 9
    Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982; 9: 78993.
  • 10
    Bombardier C, Ware J, Russell IJ, Larson M, Chalmers A, Read JL. Auranofin therapy and quality of life in patients with rheumatoid arthritis: results of a multicenter trial. Am J Med 1986; 81: 56578.
  • 11
    Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 1992; 45: 13415.
  • 12
    Nunnally JC, Bernstein IH. Psychometric theory. New York: McGraw-Hill; 1994.
  • 13
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 30710.
  • 14
    Bland JM, Altman DG. Comparing two methods of clinical measurement: a personal history. Int J Epidemiol 1995; 24 Suppl 1: S7S14.
  • 15
    Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multidimensional matrix. Psychol Bull 2000; 56: 81105.
  • 16
    Anastasi A. Psychological testing. New York: MacMillan Publishing Company; 1990.
  • 17
    Greenwood MC, Doyle DV, Ensor M. Does the Stanford Health Assessment Questionnaire have potential as a monitoring tool for subjects with rheumatoid arthritis? Ann Rheum Dis 2001; 60: 3448.
  • 18
    Guzman J. Disability scores in DMARD trials: what is a clinically important change? [abstract] Arthritis Rheum 1996; 39 Suppl 9: S208.
  • 19
    Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996; 313: 1200.
  • 20
    Wolfe F. Which HAQ is best? A comparison of the HAQ, MHAQ and RA-HAQ, a difficult 8 item HAQ (DHAQ), and a rescored 20 item HAQ (HAQ20): analyses in 2,491 rheumatoid arthritis patients following leflunomide initiation. J Rheumatol 2001; 28: 9829.
  • 21
    Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Feslon DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 77899.